ALFA FinderBSE filing, NSE: THEMISMED. Summary written from the filing by ALFA Finder's alert engine.
Themis Medicare Ltd: key numbers
- Share price
- ₹101.58
- Market cap
- ₹935.5 Cr
- Revenue (annual)
- ₹342.2 Cr
- Net profit (annual)
- ₹1.14 Cr
- P/E (TTM)
- 23.4×Sector 43.4×
- Promoter holding
- 67.11%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Themis Medicare Ltd
All →Themis Medicare Other Announcement
Themis Medicare has filed a revised September 2026 quarter shareholding pattern. It reclassifies trustees as promoter group and adds OSS Software Solutions as a nil-holding promoter group member.
Themis Medicare Board Meeting Date
Themis Medicare's board is scheduled for November 5, 2026, to approve quarterly and half-year financial results. The trading window remains closed until 48 hours post-results publication.
Themis Medicare Share Pledge
Promoter Vividhmargi pledged 15 lakh Themis Medicare shares for a Rs 135 Crore borrowing. Total encumbrance rises to 4.89% of capital.
- Value
- ₹135.0 Cr
Themis Medicare Management Change
Themis Medicare proposes re-appointing Independent Director Bhaskar Vemban Iyer for a second five-year term from 12 November 2026. Postal ballot notice dispatched to members seeking approval.
Themis Medicare Annual General Meeting
Themis Medicare seeks shareholder approval via postal ballot for a special resolution re-appointing Mr. Bhaskar Iyer as Independent Director for a second five-year term. Remote e-voting runs 24 October to 22 November 2026.
Themis Medicare Other Announcement
Themis Medicare Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31(1)(b).
Other annual report announcements
All →Generic Engineering Construction and Projects Annual Report
Generic Engineering filed its FY2025-26 Annual Report ahead of its 32nd AGM on 30 November 2026. The filing covers board changes and a planned bank-funded EPC expansion.
Vineet Laboratories Annual Report
Vineet Laboratories filed its FY 2025-26 Annual Report, which marks its turnaround and recapitalisation year. The AGM is scheduled for 30 November 2026.
Indrayani Biotech Annual Report
Indrayani Biotech has filed its 34th Annual Report for FY2025-26, containing the AGM notice for 30 November 2026 by VC/OAVM. The chairman notes a Rights Issue was initiated in October 2026 to raise capital.
ESDS Software Solution Annual Report
ESDS Software Solution submitted its FY2025-26 Annual Report along with the AGM notice. The AGM is on 30 November 2026 via VC/OAVM, with remote e-voting.
The Orissa Minerals Development Company Annual Report
Orissa Minerals Development Company filed its FY 2025-26 Annual Report and 108th AGM notice, with the AGM set for 30 November 2026. The filing is a Regulation 34 intimation with no transaction or financial event.
Viksit Engineering Annual Report
Viksit Engineering filed its 44th Annual Report for FY 2025-26 with BSE. The report includes notice of the AGM on 30 November 2026.